LIBRETTO-001 cohort 7: A single-arm, phase 2 study of neoadjuvant selpercatinib in patients with resectable stage IB-IIIA RET fusion-positive NSCLC Meeting Abstract
| Authors: | Rajaram, R.; Sholl, L. M.; Dacic, S.; Goldman, J. W.; Tan, D. S. W.; Gautschi, O.; Loong, H. H. F.; De Braud, F. G.; Massarelli, E.; Levy, B. P.; Dy, G. K.; Kang, S.; Szymczak, S.; Chao, B. H.; Drilon, A. E. |
| Abstract Title: | LIBRETTO-001 cohort 7: A single-arm, phase 2 study of neoadjuvant selpercatinib in patients with resectable stage IB-IIIA RET fusion-positive NSCLC |
| Meeting Title: | 2022 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 40 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2022 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2022-06-01 |
| Language: | English |
| ACCESSION: | WOS:000863680305109 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2022.40.16_suppl.TPS8594 |
| Notes: | Meeting Abstract: TPS8594 -- Meeting also held virtually -- Source: Wos |
